The bioavailability of residues of the furazolidone metabolite 3‐amino‐2‐oxazolidinone in porcine tissues and the effect of cooking upon residue concentrations

References

• Baer , J. E. , Jacob , T. A. and Wolf , F. J. 1977 . Cambendazole and nondrug macromolecules in tissue residues . Journal of Toxicology and Environmental Health , 2 : 895 – 903 .
   PubMed Web of Science ®Google Scholar
• Bos , R. P. , Neis , J. M. , van Gemert , P. J. L. and Henderson , P. Th. 1983 . Mutagenicity testing with the Salmonella/hepatocyte and the Salmonella/microsome assays. A comparative study with some known genotoxic compounds . Mutation Research , 124 : 103 – 112 .
   PubMed Web of Science ®Google Scholar
• Gottschall , D. W. and Wang , R. 1995 . Depletion and bioavailability of [14C] furazolidone residues in swine tissues . Journal of Agricultural and Food Chemistry , 43 : 2520 – 2525 .
   Web of Science ®Google Scholar
• Hoogenboom , L. A. P. , Tomassini , O. , Oorsprong , M. B. M. and Kuiper , H. A. 1991 . Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone . Food and Chemical Toxicology , 29 : 185 – 191 .
   PubMed Web of Science ®Google Scholar
• Hoogenboom , L. A. P. , Berghmans , M. C. J. , Polman , T. H. G. , Parker , R. and Shaw , I. C. 1992 . Depletion of protein‐bound furazolidone metabolites containing the 3‐amino‐2‐oxazolidinone side‐chain from liver, kidney and muscle tissues from pigs . Food Additives and Contaminants , 9 : 623 – 630 .
   PubMed Web of Science ®Google Scholar
• Innes , J. R. M. , Ulland , B. M. , Valerio , M. G. , Petrucelli , L. , Fishbein , L. , Hart , E. R. , Pallotta , A. J. , Bates , R. R. , Falk , H. L. , Gart , J. J. , Klein , M. , Mitchell , I. and Peters , J. 1969 . Bioassay of pesticides and industrial chemicals for tumorigenicity in mice: a preliminary note . Journal of the National Cancer Institute , 42 : 1101 – 1114 .
   PubMed Web of Science ®Google Scholar
• Mccracken , R. J. and Kennedy , D. G. 1997 . Determination of the furazolidone metabolite, 3‐amino‐2‐oxazolidinone, in porcine tissue using thermospray liquid chromatography‐mass spectrometry and the occurrence of the residues in Northern Ireland pigs . Journal of Chromatography A , 691 : 87 – 94 .
   Web of Science ®Google Scholar
• Mccracken , R. J. , Blanchflower , W. J. , Rowan , C. , Mccoy , M. A. and Kennedy , D. G. 1995 . Determination of furazolidone in porcine tissue using thermospray liquid chromatography‐mass spectrometry and a study of the pharmacokinetics and stability of its residues . Analyst , 120 : 2347 – 2351 .
   PubMed Web of Science ®Google Scholar
• Mccracken , R. J. , Mccoy , M. A. and Kennedy , D. G. 1997 . The prevalence and possible causes of bound and extractable residues of the furazolidone metabolite: 3‐amino‐2‐oxazolidinone in porcine tissues . Food Additives and Contaminants , 14 : 287 – 294 .
   PubMed Web of Science ®Google Scholar
• Nouws , J. F. M. and Laurensen , J. 1990 . Postmortal degradation of furazolidone and furaltadone in edible tissues of calves . Veterinary Quarterly , 12 : 56 – 59 .
   PubMed Web of Science ®Google Scholar
• Rose , M. D. , Shearer , G. and Farrington , W. H. H. 1995 . The effect of cooking on veterinary drug residues in food: 1. clenbuterol . Food Additives and Contaminants , 12 : 67 – 76 .
   PubMed Web of Science ®Google Scholar
• Rose , M. D. , Bygrave , J. , Farrington , W. H. H. and Shearer , G. 1996 . The effect of cooking on veterinary drug residues in food: 4. oxytetracycline . Food Additives and Contaminants , 13 : 275 – 286 .
   PubMedGoogle Scholar
• Stern , I. J. , Hollifield , R. D. , Wilk , S. and Buzard , J. A. 1967 . The anti‐monoamine oxidase effects of furazolidone . Journal of Pharmacology and Experimental Therapeutics , 156 : 492 – 499 .
   PubMed Web of Science ®Google Scholar
• Van Koten‐Vermeulen , J. E. M. , Wouters , M. F. A. and VanLeeuwen , F. X. R. 1993 . “ Toxicological evaluation of certain veterinary drug residues in food ” . In Report of the 40th meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) , 85 – 123 . Geneva : World Health Organization .
   Google Scholar
• Vroomen , L. H. M. , Berghmans , M. C. J. , Groten , J. P. , Koeman , J. H. and Van Bladeren , P. J. 1988 . Reversible interaction of a reactive intermediate derived from furazolidone with gluthathione and protein . Toxicology and Pharmacology , 95 : 53 – 60 .
   PubMed Web of Science ®Google Scholar
• Vroomen , L. H. M. , Berghmans , M. C. J. , Van Bladeren , P. J. , Groten , J. P. , Wissink , C. J. and Kuiper , H. A. 1990 . In vivo and in vitro metabolic studies of furazolidone: a risk evaluation . Drug Metabolism Reviews , 22 : 663 – 676 .
   PubMed Web of Science ®Google Scholar
• Wolf , F. J. , Alvaro , R. , Steffens , J. J. , Wolf , D. E. , Koniuszy , F. R. , Green , M. L. and Jacob , T. A. 1984 . Tissue residues due to ronidazole: bioavailability of residues in swine muscle on ingestion by the rat . Journal of Agricultural and Food Chemistry , 32 : 711 – 714 .
   Web of Science ®Google Scholar
• To whom correspondence should be addressed.
   Google Scholar